Inhibition of astroglial NF-kappaB enhances oligodendrogenesis following spinal cord injury
- Valerie Bracchi-Ricard†1,
- Kate L Lambertsen†1, 2,
- Jerome Ricard1,
- Lubov Nathanson3,
- Shaffiat Karmally1,
- Joshua Johnstone1,
- Ditte G Ellman2,
- Beata Frydel1,
- Dana M McTigue4 and
- John R Bethea1Email author
© Bracchi-Ricard et al.; licensee BioMed Central Ltd. 2013
Received: 4 March 2013
Accepted: 12 July 2013
Published: 23 July 2013
Astrocytes are taking the center stage in neurotrauma and neurological diseases as they appear to play a dominant role in the inflammatory processes associated with these conditions. Previously, we reported that inhibiting NF-κB activation in astrocytes, using a transgenic mouse model (GFAP-IκBα-dn mice), results in improved functional recovery, increased white matter preservation and axonal sparing following spinal cord injury (SCI). In the present study, we sought to determine whether this improvement, due to inhibiting NF-κB activation in astrocytes, could be the result of enhanced oligodendrogenesis in our transgenic mice.
To assess oligodendrogenesis in GFAP-IκBα-dn compared to wild-type (WT) littermate mice following SCI, we used bromodeoxyuridine labeling along with cell-specific immuno-histochemistry, confocal microscopy and quantitative cell counts. To further gain insight into the underlying molecular mechanisms leading to increased white matter, we performed a microarray analysis in naïve and 3 days, 3 and 6 weeks following SCI in GFAP-IκBα-dn and WT littermate mice.
Inhibition of astroglial NF-κB in GFAP-IκBα-dn mice resulted in enhanced oligodendrogenesis 6 weeks following SCI and was associated with increased levels of myelin proteolipid protein compared to spinal cord injured WT mice. The microarray data showed a large number of differentially expressed genes involved in inflammatory and immune response between WT and transgenic mice. We did not find any difference in the number of microglia/leukocytes infiltrating the spinal cord but did find differences in their level of expression of toll-like receptor 4. We also found increased expression of the chemokine receptor CXCR4 on oligodendrocyte progenitor cells and mature oligodendrocytes in the transgenic mice. Finally TNF receptor 2 levels were significantly higher in the transgenic mice compared to WT following injury.
These studies suggest that one of the beneficial roles of blocking NF-κB in astrocytes is to promote oligodendrogenesis through alteration of the inflammatory environment.
KeywordsNF-kappaB Spinal cord injury Astrocyte Oligodendrocyte Microglia CXCR4 TNFR2 Toll-like receptor
Spinal cord injury (SCI) is a devastating condition affecting millions of people worldwide. Following the initial trauma to the spinal cord, with loss of cells at the site of impact, a second phase injury occurs characterized in part by secretion of cytokines and chemokines produced at the lesion site leading to recruitment of peripheral leukocytes to the injury . While an inflammatory response is necessary to clear debris at the site of injury it, if uncontrolled, leads to an enlargement of the initial lesion, with additional axonal damage, oligodendrocyte cell death and demyelination with concomitant increased loss of neurological function. The loss of oligodendrocytes, however, may be replaced by proliferating nerve/glial antigen 2+ (NG2) cells, also known as oligodendrocyte precursor cells (OPCs) . These OPCs are able to migrate to the injury site and differentiate into mature myelinating oligodendrocytes if the environment is permissive . The lack of effective remyelination is often due to the presence of oligodendrocyte differentiation inhibitors in the injury environment, which can originate from astrocytes, demyelinated axons or myelin debris [4, 5]. Until recently, the contribution of astrocytes to demyelinating diseases was underestimated. However, our laboratory and others have now established a prominent role of astrocytes in vivo in the pathogenesis of experimental autoimmune encephalomyelitis (EAE) [6–8] and axonal degeneration  and in vitro an increasing number of astroglial-derived factors have been identified that modulate myelination processes [7, 10, 11].
One of the ways astrocytes respond to injury is by producing cytokines and chemokines, many of which are regulated by NF-κB. To study the role of astroglial NF-κB in the pathogenesis of SCI, we previously generated transgenic mice (GFAP-IκBα-dn) in which NF-κβ is specifically inactivated in astrocytes by overexpression of a truncated form of the inhibitor IκBα (IκBα-dn) under the control of the glial fibrillary acidic protein (GFAP) promoter . In this previous study, we demonstrated that blocking NF-κB activation in astrocytes resulted in reduced expression of cytokines and chemokines such as CXCL10, CCL2 and transforming growth factor beta, and in a smaller lesion volume and increased white matter sparing along with a significant improvement in locomotor function following SCI. Further studies showed that inhibition of astroglial NF-κB promoted axonal sparing and sprouting of supraspinal and propriospinal axons, which are essential for locomotion . In a brain injury model astroglial NF-κB was also found to play a central role in directing immune-glial interactions by regulating the expression of CCL2 through STAT2 . One explanation for the observed larger volume of white matter in our transgenic mice could be a reduction in oligodendrocyte cell death or an increase in oligodendrogenesis. Here, we are addressing the role of astroglial NF-κB in regulating oligodendrogenesis in the chronically injured spinal cord.
Adult (3 to 4 months) female GFAP-IκBα-dn (IκBα-dn) transgenic mice were generated and characterized in our laboratory . All animals, IκBα-dn and wild-type (WT) littermates (LM), were kept as a colony in a virus/antigen-free environment at the University of Miami Miller School of Medicine, Miami, FL, USA. IκBα-dn mice were obtained by breeding heterozygous IκBα-dn males with WT females. Mice were housed under diurnal lightning conditions and allowed free access to food and water.
Induction of spinal cord injury
Surgeries were performed at the Animal and Surgical Core Facility of the Miami Project to Cure Paralysis according to protocols approved by the Institutional Animal Care and Use Committee of the University of Miami. Contusion injury was induced with the Infinite Horizon Device (Precision Systems and Instrumentation LLC, Kentucky, USA). Female IκBα-dn (21.5 ± 2.7 g) and WT LM (21.0 ± 2.8 g) mice were anesthetized intraperitoneally (i.p.) using a ketamine (100 mg/kg, VEDCO Inc., Saint Joseph, MO, USA)/xylazine (10 mg/kg, VEDCO) cocktail, and a laminectomy was performed at the vertebral level T9. The contusion device was lowered onto the spinal cord at a predetermined impact force of 50 kdynes (moderate injury) and the mice were injured by a rapid displacement of the impounder resulting in a spinal cord displacement of 400 to 500 μm. Immediately after surgery, mice were sutured and injected subcutaneously (s.c.) with 1 ml lactated Ringer’s Injection USP (B. Braun, L7502, Bethlehem, PA, USA) to prevent dehydration and housed separately in a recovery room, where their post-surgical health status was observed. Thereafter, mice were returned to the conventional animal facility, where they were observed bi-daily for activity level and general physical condition. Manual bladder expression was performed twice a day until bladder function was regained. In addition, mice received s.c. prophylactic injections of antibiotic gentamicin (40 mg/kg, Hospira Inc., Lake Forest, IL, USA) for 7 days following SCI to prevent urinary tract infections. Mice were allowed 3 days, 3, 6 or 7 weeks survival.
Bromodeoxyuridine injections and tissue processing
Mice in the 7 weeks survival group were injected i.p. with bromodeoxyuridine (BrdU; 50 μg/g body weight; Sigma, St. Louis, MO, USA) once a day for 7 days starting at week 5 post-SCI and were allowed to survive for 1 more week. Then the mice, naïve, 3 days, 6 and 7 weeks survival, were deeply anesthetized and perfused through the left ventricle using ice cold 0.01 M PBS followed by ice cold 4% paraformaldehyde (PFA) in PBS. The spinal cords were post-fixed in 4% PFA followed by immersion in 25% sucrose in PBS overnight. Spinal cords were cut into 1-cm segments centered on the injury site and then embedded in optimal cutting temperature (OCT) compound (VWR International, Arlington Heights, IL, USA), frozen and cut into 10 series of 25 μm transverse cryostat sections. Sections were stored at -20°C until further use.
Antibodies used for immunohistochemical staining were rat anti-mouse CD11b (1:600, AbDSerotec, Hercules, CA, USA, MCA711 clone 5C6) and rabbit anti-NG2 (1:500, Chemicon, Billerica, MA, USA, AB5320). Isotype control antibodies were rabbit immunoglobulin (Ig)G (1:20,000, DakoCytomation, Carpinteria, CA, USA, X0903) and rat IgG2b (1:600, Biosite, Plymouth Meeting, PA, USA, IG-851125). Visualization of CD11b+ microglia-macrophages was performed using the three-step biotin-streptavidin-horseradish peroxidase technique described by Lambertsen and colleagues, 2001 . Visualization of NG2+ OPCs was performed using peroxidase-labeled “ready-to-use” EnVision+ polymer (K4300, DakoCytomation) according to the manufacturer’s instructions on spinal cord sections demasked using 0.5% Pepsin (Sigma-Aldrich, P-7012) in HCl and H2O for 10 minutes at 37°C. Sections were counterstained using Hematoxylin Gills or Toluidine blue. Isotype controls were devoid of staining (not shown).
Estimation of the total number of CD11b+ and NG2+cells
Using an approximated stereological counting technique unaffected by shrinkage/tissue resorption , we estimated the total number of CD11b+ and NG2+ cells in the spinal cord of naïve IκBα-dn and WT mice and the total number of CD11b+ cells in IκBα-dn and WT mice that had survived 3 days and 6 weeks after SCI. Briefly, cells with a clearly identifiable H&E or Toluidine Blue stained nucleus in conjunction with a detectable immunohistochemical signal were counted on approximately 13 sections in naïve cords and at 3 days, and on 17 sections 6 weeks after injury separated by 250 μm from each animal, using a 100× objective and a 2,470 μm2 frame area stepping 150 μm/150 μm in the XY-position using the CAST Grid System from Olympus (Ballerup, Denmark). The total number (N) of cells in each animal was estimated using the formula: Estimate of N = ∑Q × (1/ssf) × (1/asf) × (1/tsf), where 1/tsf is the thickness sampling fraction (1/tsf = 1), 1/ssf the sampling section fraction (1/ssf = 10), and 1/asf the area sampling fraction (22,500/2,470) as previously described . In naïve mice and for the time point of 3 days we, for consistency, analyzed a total of 3.25 mm long piece of mouse spinal cord, 1.625 mm on pre- and post-epicenter. For the time point of 6 weeks we analyzed a 4.25 mm long piece of mouse spinal cord, 2.125 mm on both sides of the epicenter.
Estimation of the lesion and white matter volumes
The lesion volume and the white matter volume were estimated on Luxol Fast Blue serial sections counterstained with H&E using the Neurolucida software (MBF Bioscience, Williston, VT, USA) as previously described .
For BrdU immunofluorescent staining, cryostat sections were thawed at room temperature for 5 minutes, rinsed in 1X PBS, and processed for antigen retrieval using 2N HCl for 30 minutes at 37°C. The sections were then neutralized for 10 minutes in 0.1 M sodium borate (pH 8.5) and rinsed in 1X PBS. After blocking 30 minutes in 5% BSA/5% normal goat serum (NGS)/0.3% Triton X100/PBS, rat anti-BrdU antibody (1:200, Novus Biologicals, Littleton, CO, USA; diluted in 4% BSA/3% NGS/0.1% Triton X100/PBS) was applied to the sections in combination with either mouse anti-adenomatous polyposis coli (APC; clone CC1) antibody (1:500, Calbiochem, Billerica, MA, USA) or rabbit anti-NG2 antibody (1:500, Chemicon), and incubated overnight at 4°C. For triple immunostaining we used rat anti-BrdU (1:200, Novus Biologicals) and rabbit anti-Olig2 (1:500, Millipore, Billerica, MA, USA) with either mouse anti-NG2 (1:200, Millipore) or mouse anti-APC (1:500, Calbiochem). Following extensive rinses in 1X PBS, Alexa-conjugated secondary antibodies (1:500, Molecular Probe, Grand Island, NY, USA) were applied for 30 min at room temperature. Sections were finally rinsed and mounted with Vectashield (Vector Laboratories, Burlingame, CA, USA). To estimate the number of BrdU+/CC1+, BrdU+/NG2+, and total CC1+-cells following SCI, serial sections were counted using Zeiss Axiovert 200M fluorescent microscope (63X objective; Thornwood, NY, USA) and Stereo Investigator software (MicroBrightField, Williston, VT, USA) for unbiased stereological estimation of cell numbers. For each section a 50 × 50 μm counting frame and a 120 × 120 μm grid was used to count the cells at 250 μm intervals. A total number of 11 sections, centered on the lesion site, were counted. For the number of CC1+ cells in the naïve thoracic spinal cord, a total number of 5 sections were counted.
For CXCR4 immunostaining, thawed cryostat sections were fixed and permeabilized in ice-cold acetone for 10 minutes at −20°C, then rinsed in PBS and blocked for 1 hour in 10% NGS/PBS and 30 minutes in 5% BSA/PBS. Sections were then incubated overnight with rabbit anti-CXCR4 antibody (1:500, Abcam, Cambridge, MA, USA) diluted in 5% BSA/1% NGS/PBS in combination with either mouse anti-GFAP (1:500, BD Pharmingen, San Jose, CA, USA) or mouse anti-APC (1:500, Calbiochem) antibodies. Alexa-conjugated secondary antibodies (1:500, Molecular Probes) diluted in 5% BSA/1% NGS/PBS were applied to the rinsed sections for 30 minutes at room temperature. Then sections were rinsed and mounted with Vectashield with 4',6-diamidino-2-phenylindole (DAPI) (Vector Laboratories). For toll-like receptor 4 (TLR4; 1:50, Santa Cruz, Dallas, TX, USA) and TNF receptor 2 (TNFR2; 1:200, Santa Cruz), a similar protocol was used except that the sections were permeabilized and blocked in 5% BSA/5% NGS/0.3% Triton X100/PBS. Nuclei were visualized using a DAPI counterstain. Images were obtained with an Olympus FluoView 1000 confocal microscope.
Total RNA isolation
Total RNA was isolated from spinal cord samples (1.5 cm centered on the lesion site) using TRIzol reagent (Invitrogen, Grand Island, NY, USA) according to the manufacturer’s directions. Precautions were taken to preserve RNA integrity during the isolation, including rapid dissection on ice with RNase-free dissecting tools followed by flash-freezing in liquid nitrogen of the spinal cord segment sample as previously described by Brambilla and colleagues . RNA integrity was determined with the Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA, USA).
Microarray analysis and data processing
Microarray experiments were conducted at the University of Miami DNA and Microarray Core Facility (http://www.mihg.org/weblog/core_resources/2007/11/microarray-and-gene-expression.html) using Agilent Whole Mouse Genome Oligo microarrays (Agilent Technologies). Arrays were scanned at a 5 μm resolution using a GenePix 4000B scanner (Axon Instruments at Molecular Devices) and images analyzed with the software GenePix Pro 6.1 (Axon Instruments at Molecular Devices, LLC, Sunnyvale, CA, USA). Extracted data were transferred to the software Acuity 4.0 (Axon Instruments at Molecular Devices) for quality control. Features for further analysis were selected according to the following quality criteria: at least 90% of the pixels in the spot with intensity higher than background plus two standard deviations; less than 2% saturated pixels in the spot; signal to noise ratio (ratio of the background subtracted mean pixel intensity to standard deviation of background) 3 or above for each channel; spot diameter between 80 and 110 μm; regression coefficient of ratios of pixel intensity 0.6 or above. To identify significantly expressed genes the R software LIMMA (Bioconductor, open source software at http://www.bioconductor.org)  was used. “Within array” normalization was carried out with Lowess normalization and “between arrays” normalization with the “quantile” algorithm in the LIMMA package. Differential expression and false discovery rate (FDR) were assessed using a linear model and empirical Bayes moderated F statistics [18, 19]. Genes with FDR below 1% were considered statistically significant. All primary microarray data were submitted to the public database at the GEO website (http://www.ncbi.nih.gov/geo; record number: GSE46695). Selected genes were classified according to Gene Ontology category “biological process” using Onto-Express . Pathway analysis was performed with WebGestalt . Hierachical clustering was performed using GeneSpring 10.0 (Agilent Technologies). All experiments were performed in three replicates/groups/time points.
Quantitative real-time PCR
An aliquot of 2 μg of spinal cord RNA from each time point was reverse transcribed using the omniscript RT-PCR kit (Qiagen, Valencia, CA, USA) as previously described . qPCR was performed with the Rotor-Gene 3000 Real Time Cycler (Corbett Research, Valencia, CA, USA) on cDNA samples with TAQurate GREEN Real-Time PCR MasterMix (Epicentre Biotechnologies, Madison, WI, USA) as previously described  for the following genes: CXCR4 (forward primer: TGT GAC CGC CTT TAC CCC GAT AGC, reverse primer: TTC TGG TGG CCC TTG GAG TGT GAC), TLR4 (forward primer: TGC CCC GCT TTC ACC TC, reverse primer: ACC AAC GGC TCT GAA TAA AGT GT), Lingo-1 (forward primer: GAC TGC CGG CTG CTG TGG GTG TT, reverse primer: CCG GCG GCA GGT GAA GTA GTT GG), Sox17 (forward primer: CGG CGC AAG CAG GTG AAG, reverse primer: GGC TCC GGG AAA GGC AGA C), CNPase (forward primer: AGA TGG TGT CCG CTG ATGCTT AC, reverse primer: CTC CCG CTC GTG GTT GGT), CD11b (forward primer: GCC CCA AGA AAG TAG CAA GGA GTG, reverse primer: TAC GTG AGC GGC CAG GGT CTA AAG) and ICAM1 (forward primer: TGA GCG AGA TCG GGG AGG ACA G, reverse primer: GTG GCA GCG CAG GGT GAG GT). Relative expression was calculated by comparison with a standard curve after normalization to β-actin .
Spinal cords (1.5 cm centered on the injury site) were homogenized in 300 μl radio immunoprecipitation assay buffer (0.01 M sodium phosphate pH 7.2, 0.15 M NaCl, 1% NP40, 1% sodium deoxycholate, 0.1% SDS, 2 mM EDTA) supplemented with complete protease inhibitor cocktail (Roche, Indianapolis, IN, USA), incubated for 30 minutes at 4°C on an end-over-end rotator, and centrifuged at 4°C for 10 minutes at 14,000 rpm. The supernatant was then transferred to a fresh tube on ice and an aliquot was used for protein quantification using the DC Protein Assay (Biorad, Hercules, CA, USA). Equal amounts of proteins were resolved by SDS-PAGE on 10% or 15% gels, transferred to nitrocellulose membranes, and blocked in 5% nonfat milk in 0.1 M Tris buffered saline-triton (TBS-T) for 1 hour at room temperature. Membranes were probed with an antibody recognizing either proteolipid protein (PLP; mouse monoclonal, Millipore, 1:250), CXCR4 (rabbit polyclonal, Abcam, 1:500), Foxc2 (mouse monoclonal, Santa Cruz, 1:500), TLR4 (mouse monoclonal, Santa Cruz, 1:200), TNFR2 (rabbit polyclonal, Santa Cruz, 1:200), CXCR7 (rabbit polyclonal, GeneTex, Irvine, CA, USA, 1:1000) followed by horseradish peroxidase–conjugated secondary antibody (GE Healthcare, Little Chalfont, Buckinghamshire, UK, 1:2000). Proteins were visualized with a chemiluminescent kit (ECL; GE Healthcare). Blots were also probed for β-actin (mouse monoclonal, Santa Cruz, 1:500) as a loading control. The data were analyzed using Quantity One software (Biorad).
One-way or two-way analysis of variance (ANOVA) followed by the appropriate post hoc test and Student’s t-test (one-tailed and two-tailed). Statistical analyses were performed using Prism 4.0b software for Macintosh, GraphPad Software, San Diego, CA, USA, http://www.graphpad.com. Data are presented as mean ± SEM. Statistical significance was established for P < 0.05.
Oligodendrogenesis is increased following spinal cord injury in mice lacking functional NF-κB signaling in astrocytes
Microarray analysis of the spinal cord from wild-type and IκBα-dn mice following spinal cord injury
Microarray data summary
Total number of differentially expressed genes
Genes under expressed in GFAP-IκBα-dn mice
Genes over expressed in GFAP-IκBα-dn mice
Genes associated directly or indirectly with myelination
GFAP-IκBα-dn mice versus wild-type mice at 6 weeks
Thus far we have presented data suggesting that inhibiting NF-κB activation in astrocytes promotes an environment favorable for oligodendrogenesis (Figures 2 and 3). To explore oligodendrogenesis further, we focused on genes previously demonstrated to be important in cell proliferation and oligodendrogenesis such as Sox17 and Lingo-1 [24, 25]. While not a specific indicator of oligodendrogenesis, we found that Ki67, a general marker of proliferation, was significantly elevated 3 days post-SCI in both WT and IκBα-dn mice relative to naïve animals but only in IκBα-dn mice 6 weeks post-SCI (Figure 3A). Some possible sources for Ki67 expression, besides infiltrating immune cells, are also OPCs. Sox17, a transcription factor important in oligodendrocyte development , was significantly upregulated in IκBα-dn mice 6 weeks post-SCI (Figure 3B), while Lingo-1, a negative regulator of oligodendrogenesis , was significantly reduced in IκBα-dn mice at this time point (Figure 3F). These findings support the data presented in Figure 2 showing significantly increased numbers of BrdU+CC1+ oligodendrocytes, significantly increased numbers of CC1+ oligodendrocytes and significantly increased PLP levels in IκBα-dn mice, suggesting increased oligodendrogenesis in the IκBα-dn mice compared to WT mice.
Inhibition of astroglial NF-κB results in an altered inflammatory state that is supportive of oligodendrogenesis after spinal cord injury
Since TLR4, a pattern recognition receptor important in innate immunity that has been shown to modulate myelination, astrogliosis and macrophage activation [34, 36], was found to be up-regulated in the microarray at 6 weeks post-injury in the IκBα-dn mice, we confirmed by qPCR the significant increase in TLR4 mRNA in IκBα-dn mice (Figure 3D). We further examined the cellular expression of TLR4 in injured spinal cord tissue from WT and IκBα-dn mice by immunohistochemistry. TLR4 immunoreactivity colocalized almost exclusively with CD11b+ microglia/leukocytes in both WT and IκBα-dn mice and showed stronger immunoreactivity in the injured spinal cord of the IκBα-dn mice compared to WT (Figure 4C), suggesting a difference in the state of activation of microglia/leukocytes between the two genotypes. This was further supported by the finding of a significant increase in TLR4 protein levels in IκBα-dn mice 6 weeks post-SCI compared to WT LM (P < 0.05, Figure 4D).
CXCR4 expression is increased on oligodendrocytes following spinal cord injury
Since the transcription factor Foxc2 is important in CXCR4 regulation , we further compared Foxc2 expression at this time point using western blotting. In line with the findings of significantly increased protein CXCR4 levels in IκBα-dn compared to WT mice, Foxc2 protein levels were also significantly upregulated 6 weeks post-SCI in IκBα-dn compared to WT mice (Figure 5D).
Furthermore, CXCR7 has been implicated in the pathophysiology of demyelination and axonal injury in EAE where antagonism of CXCR7 promotes functional recovery and reduces axonal injury . CXCR7 was not in the microarray analysis but based upon the role it plays in EAE and our present results on CXCR4, we investigated CXCR7 protein expression following SCI (Figure 5E). We detected a significant increase in CXCR7 expression 6 weeks post-SCI in WT mice but not in IκBα-dn mice compared to naïve spinal cords (Figure 5E), suggesting that CXCR7 expression is significantly reduced by inhibition of NF-κB in astrocytes.
IκBα-dn mice displayed increased TNFR2 expression compared to wild-type mice after spinal cord injury
Collectively, our data suggest that sustained expression of TNFR2 in IκBα-dn mice enhances the expression of CXCR4 and thereby promotes an environment supportive of oligodendrogenesis and remyelination. Furthermore, CXCR7 is expressed on astrocytes and signals through NF-κB suggesting that the reduced neuropathology in our IκBα-dn mice could be due to impaired CXCR7 expression and signaling in these mice.
In a previous study, we showed that mice lacking functional NF-κB signaling in astrocytes (GFAP-IκBα-dn transgenic mice) recover better following moderate spinal cord contusion, with a significant improvement in locomotor function that correlates with a smaller lesion area and a larger area of white matter preservation compared to injured WT LM . Since the mice were generated several years ago, we confirmed that they still retained the same phenotype following SCI and found that the GFAP-Iκbα-dn mice still did perform significantly better than the WT mice on the Basso Mouse Scale following moderate SCI, supported by a smaller lesion size and more myelin 6 weeks post-SCI. The larger white matter volume in the IκBα-dn transgenic mice could be due to sparing of oligodendrocytes from cell death and/or to an increase in oligodendrogenesis. In the present paper, we demonstrate that there is indeed an increase in oligodendrogenesis in the IκBα-dn transgenic mice compared to the WT LM 6 to 7 weeks post-SCI. In the naïve mice we did not find any differences in the number of oligodendrocytes or the amount of myelin between WT and transgenic mice suggesting that blocking NF-κB signaling in astrocytes under naïve conditions does not affect myelination. However, following SCI we found a large increase in the number of newly formed BrdU+/CC1+ oligodendrocytes, suggesting that astroglial NF-κB directly or indirectly affects the differentiation of OPC into mature, myelinating oligodendrocytes. In fact, a recent study showed that reactive astrocytes from the injured spinal cord can inhibit oligodendrocyte differentiation in vitro . Many others have also shown that astrocytes can directly modulate myelination in vitro via the release of a number of secreted factors, depending on culture conditions [7, 10]. In our study, it is so far unknown whether the decreased expression of a NF-κB-regulated gene has a direct effect on oligodendrocyte maturation or an indirect effect through other cells such as microglia and/or infiltrating macrophages. Indeed, factors secreted by macrophages from the injured spinal cord have been shown to inhibit growth of NG2+ cells in vitro . When we examined the distribution of the BrdU+/CC1+ cells, we found numerous double immunolabeled cells located around the epicenter in the IκBα-dn transgenic mice compared to the WT LM mice, suggesting that while the lesion epicenter in the WT mice is inhibitory for oligodendrocyte differentiation, the epicenter environment in the transgenic mice is more permissive and may allow for a better survival of newly generated oligodendrocytes. To gain insight into the molecular mechanisms underlying increased oligodendrogenesis, we performed a microarray analysis on naïve and injured spinal cords at 3 days, 3 and 6 weeks post-SCI and found the largest number of differentially regulated genes between WT and GFAP-IκBα-dn mice at the more chronic time point. Since analysis of the set of genes pointed to differences in the inflammatory response with upregulation of genes such as CD11b, TLR4, CXCL12, and CXCR4 in IκBα-dn mice compared to the WT mice, we sought to determine whether differences in the number of microglia/leukocytes could account for the observed differences. Even though we did not find any differences in terms of total number of CD11b+ cells between WT and GFAP-IκBα-dn mice 6 weeks following SCI, we found differences in TLR4 levels, with the microglia/leukocytes from the transgenic mice showing enhanced immunoreactivity compared to the WT mice. Inflammatory reactions are important in stimulating recruitment of OPCs to demyelinating areas and in the remyelination process itself [34, 51, 52]. Recently, diverse microglia/macrophage phenotypes have been identified through their expression of specific sets of genes, making them either neuroprotective and reparative or toxic to the neural cells [20, 33, 35]. Our data suggest that inhibiting astroglial NF-κB affects the activation status of microglia/leukocytes rendering them more supportive for remyelination. In fact the role of astrocytes in modulating microglia has been highlighted in a study where astrocytes from glioblastoma have been shown to suppress microglial function . It appears that the number of astrocytes may also be an important factor in the regulation of microglial function. However, we did not find any significant difference in the number of astrocytes in the spinal cord from naïve WT and IκBα-dn transgenic mice (Additional file 1).
Chemokines are essential for trafficking of leukocytes in both physiological and pathological conditions . CXCL12, also known as stromal-derived growth factor 1 or SDF-1, can act through two G-coupled receptors, CXCR4 and CXCR7. CXCL12 and its receptor CXCR4 play multiple roles both in the immune and nervous systems. CXCL12 is a highly efficacious chemoattractant for lymphocytes and monocytes but not neutrophils . CXCR4 signaling is required for the migration of neuronal precursors, axon guidance/pathfinding and maintenance of neural progenitor cells. In the mature CNS, CXCL12 modulates neurotransmission, neurotoxicity and neuroglial interactions. It activates NF-κB, stimulates the production of chemokines and cytokines and induces cell death in primary astrocytes . CXCL12 stimulates neurite growth on inhibitory CNS myelin . Regarding the role of CXCL12 in remyelination there are some divergent results as whether it promotes oligodendrocyte maturation through its receptor CXCR4  or CXCR7 . These apparent discrepancies may be due to the injury paradigm being a drug-induced demyelination of the corpus callosum in the study by Gottle and colleagues  and a myelin oligodendrocyte glycoprotein-induced EAE model in the study by Patel and colleagues . In our chronically spinal cord injured mouse model, we observed a strong induction of CXCR4 on oligodendrocytes especially in IκBα-dn mice compared to WT, which is in stark contrast with the study from Gottle and colleagues  where they did not observe any expression of CXCR4 on oligodendroglial cells in both healthy and diseased spinal cord. The pathophysiology of SCI and EAE is very distinct, which could explain some of the differences observed in models of SCI and EAE. The pattern of expression of CXCR4 appeared mostly nuclear although we also found cytoplamic/membrane staining as well. Nuclear localization of CXCR4 has been reported following binding to CXCL12 and its function in the nucleus is still speculative . As in the study by Patel and colleagues , we found CXCR4 expressed by some NG2+ cells both in WT and IκBα-dn mice. Due to the expression of CXCR4 on NG2+ cells and in oligodendrocytes, this would suggest a role in both myelination and oligodendrocyte survival. Regarding CXCR7, we observed an induction at 6 weeks in the injured WT mice, but not in the IκBα-dn mice while antagonism to CXCR7 has been reported to promote oligodendrocyte maturation  and to prevent axonal injury  in two different models of EAE.
TNF is a cytokine that plays different roles depending on the receptor it engages, being either TNFR1 or TNFR2. Originally viewed as a pro-inflammatory cytokine, knockout studies have demonstrated that TNF does not only have deleterious effects following CNS trauma or disease [29, 59], but is also involved in the repair phase specifically through its cognate TNFR2 (p75) receptor . Recently, our laboratory has demonstrated, using a specific inhibitor of soluble TNF, that signaling of membrane-bound TNF through its receptor TNFR2 was associated with axonal preservation and improved myelin compaction following EAE . Furthermore a recent study by Patel and colleagues showed that TNFR2 was required for OPC proliferation and differentiation in a drug-induced demyelination model of the corpus callosum . Therefore, we sought to determine whether TNFR2 expression was altered following SCI. Our data showed that TNFR2 expression was reduced 6 weeks following SCI in WT mice but was maintained at levels similar to the naïve conditions in our transgenic mice suggesting that signaling through TNFR2 on oligodendrocytes may have a positive effect on myelination as seen in EAE.
The fact that in the present study we observed dramatic gene changes at the more chronic time point may be explained by the biphasic infiltration of leukocytes in mice following SCI with a late peak occurring in the chronic phase 42 days after injury [61–63].
In conclusion, our data demonstrate that one of the beneficial roles of blocking NF-κB in astrocytes is to promote oligodendrogenesis through alteration of the inflammatory environment at and around the lesion site. In particular, our data suggest that astrocytes may be modulating microglial/leukocyte activation towards a phenotype that is supportive of oligodendrogenesis and repair.
Analysis of variance
Adenomatous polyposis coli
Area sampling fraction
Bovine serum albumin
Central nervous system
Experimental autoimmune encephalomyelitis
False discovery rate
Glial fibrillary acidic protein
Hmatoxylin and eosin
Nerve/glial antigen 2
Normal goat serum
Nuclear factor-kappa B
Oligodendrocyte precursor cell
Phosphate buffered saline
Polymerase chain reaction
Reverse transcriptase-polymerase chain reaction
Spinal cord injury
Sampling section fraction
Tris buffered saline-triton
Tumor necrosis factor
Tumor necrosis factor receptor
Thickness sampling fraction
This work was supported by NIH grants NS051709-06 (JRB) and The Danish MRC and the Carlsberg Foundation (KLL). The authors acknowledge the technical assistance provided by technicians Karen Rich, Inge Holst Nielsen, Dorte Lyholmer and Louise Lykkemark.
- Donnelly DJ, Popovich PG: Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol. 2008, 209: 378-388. 10.1016/j.expneurol.2007.06.009.PubMed CentralView ArticlePubMed
- Tripathi R, McTigue DM: Prominent oligodendrocyte genesis along the border of spinal contusion lesions. Glia. 2007, 55: 698-711. 10.1002/glia.20491.View ArticlePubMed
- Franklin RJ, Ffrench-Constant C: Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci. 2008, 9: 839-855. 10.1038/nrn2480.View ArticlePubMed
- Kremer D, Aktas O, Hartung HP, Kury P: The complex world of oligodendroglial differentiation inhibitors. Ann Neurol. 2011, 69: 602-618. 10.1002/ana.22415.View ArticlePubMed
- Kotter MR, Li WW, Zhao C, Franklin RJ: Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci. 2006, 26: 328-332. 10.1523/JNEUROSCI.2615-05.2006.View ArticlePubMed
- Brambilla R, Persaud T, Hu X, Karmally S, Shestopalov VI, Dvoriantchikova G, Ivanov D, Nathanson L, Barnum SR, Bethea JR: Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation. J Immunol. 2009, 182: 2628-2640. 10.4049/jimmunol.0802954.PubMed CentralView ArticlePubMed
- Moore CS, Abdullah SL, Brown A, Arulpragasam A, Crocker SJ: How factors secreted from astrocytes impact myelin repair. J Neurosci Res. 2011, 89: 13-21. 10.1002/jnr.22482.View ArticlePubMed
- Moore CS, Milner R, Nishiyama A, Frausto RF, Serwanski DR, Pagarigan RR, Whitton JL, Miller RH, Crocker SJ: Astrocytic tissue inhibitor of metalloproteinase-1 (TIMP-1) promotes oligodendrocyte differentiation and enhances CNS myelination. J Neurosci. 2011, 31: 6247-6254. 10.1523/JNEUROSCI.5474-10.2011.PubMed CentralView ArticlePubMed
- Khorooshi R, Babcock AA, Owens T: NF-kappaB-driven STAT2 and CCL2 expression in astrocytes in response to brain injury. J Immunol. 2008, 181: 7284-7291.View ArticlePubMed
- Nash B, Thomson CE, Linington C, Arthur AT, McClure JD, McBride MW, Barnett SC: Functional duality of astrocytes in myelination. J Neurosci. 2011, 31: 13028-13038. 10.1523/JNEUROSCI.1449-11.2011.View ArticlePubMed
- Wang Y, Cheng X, He Q, Zheng Y, Kim DH, Whittemore SR, Cao QL: Astrocytes from the contused spinal cord inhibit oligodendrocyte differentiation of adult oligodendrocyte precursor cells by increasing the expression of bone morphogenetic proteins. J Neurosci. 2011, 31: 6053-6058. 10.1523/JNEUROSCI.5524-09.2011.PubMed CentralView ArticlePubMed
- Brambilla R, Bracchi-Ricard V, Hu WH, Frydel B, Bramwell A, Karmally S, Green EJ, Bethea JR: Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J Exp Med. 2005, 202: 145-156. 10.1084/jem.20041918.PubMed CentralView ArticlePubMed
- Brambilla R, Hurtado A, Persaud T, Esham K, Pearse DD, Oudega M, Bethea JR: Transgenic inhibition of astroglial NF-kappa B leads to increased axonal sparing and sprouting following spinal cord injury. J Neurochem. 2009, 110: 765-778. 10.1111/j.1471-4159.2009.06190.x.PubMed CentralView ArticlePubMed
- Lambertsen KL, Gregersen R, Drojdahl N, Owens T, Finsen B: A specific a sensitive method for visualization of tumor necrosis factor in the murine central nervous system. Brain Res Brain Res Protoc. 2001, 7: 175-191. 10.1016/S1385-299X(01)00062-9.View ArticlePubMed
- Lambertsen KL, Gregersen R, Finsen B: Microglial-macrophage synthesis of tumor necrosis factor after focal cerebral ischemia in mice is strain dependent. J Cereb Blood Flow Metab. 2002, 22: 785-797.View ArticlePubMed
- West MJ, Ostergaard K, Andreassen OA, Finsen B: Estimation of the number of somatostatin neurons in the striatum: an in situ hybridization study using the optical fractionator method. J Comp Neurol. 1996, 370: 11-22. 10.1002/(SICI)1096-9861(19960617)370:1<11::AID-CNE2>3.0.CO;2-O.View ArticlePubMed
- Smyth GK, Michaud J, Scott HS: Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics. 2005, 21: 2067-2075. 10.1093/bioinformatics/bti270.View ArticlePubMed
- Smyth GK: Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004, 3: 3.
- Smyth GK, Speed T: Normalization of cDNA microarray data. Methods. 2003, 31: 265-273. 10.1016/S1046-2023(03)00155-5.View ArticlePubMed
- Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, Georgescu C, Romero R: A systems biology approach for pathway level analysis. Genome Res. 2007, 17: 1537-1545. 10.1101/gr.6202607.PubMed CentralView ArticlePubMed
- Zhang B, Kirov S, Snoddy J: WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 2005, 33: W741-W748. 10.1093/nar/gki475.PubMed CentralView ArticlePubMed
- Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, Popovich PG: Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma. 2006, 23: 635-659. 10.1089/neu.2006.23.635.View ArticlePubMed
- Nishiyama A, Komitova M, Suzuki R, Zhu X: Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat Rev Neurosci. 2009, 10: 9-22.View ArticlePubMed
- Mi S, Hu B, Hahm K, Luo Y, Kam Hui ES, Yuan Q, Wong WM, Wang L, Su H, Chu TH, Guo J, Zhang W, So KF, Pepinsky B, Shao Z, Graff C, Garber E, Jung V, Wu EX, Wu W: LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat Med. 2007, 13: 1228-1233. 10.1038/nm1664.View ArticlePubMed
- Chew LJ, Shen W, Ming X, Senatorov VV, Chen HL, Cheng Y, Hong E, Knoblach S, Gallo V: SRY-box containing gene 17 regulates the Wnt/beta-catenin signaling pathway in oligodendrocyte progenitor cells. J Neurosci. 2011, 31: 13921-13935. 10.1523/JNEUROSCI.3343-11.2011.PubMed CentralView ArticlePubMed
- Sohn J, Natale J, Chew LJ, Belachew S, Cheng Y, Aguirre A, Lytle J, Nait-Oumesmar B, Kerninon C, Kanai-Azuma M, Kanai Y, Gallo V: Identification of Sox17 as a transcription factor that regulates oligodendrocyte development. J Neurosci. 2006, 26: 9722-9735. 10.1523/JNEUROSCI.1716-06.2006.View ArticlePubMed
- Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, Chang J, Thill G, Levesque M, Zhang M, Hession C, Sah D, Trapp B, He Z, Jung V, McCoy JM, Pepinsky RB: LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci. 2005, 8: 745-751. 10.1038/nn1460.View ArticlePubMed
- Clausen BH, Lambertsen KL, Meldgaard M, Finsen B: A quantitative in situ hybridization and polymerase chain reaction study of microglial-macrophage expression of interleukin-1beta mRNA following permanent middle cerebral artery occlusion in mice. Neuroscience. 2005, 132: 879-892. 10.1016/j.neuroscience.2005.01.031.View ArticlePubMed
- Lambertsen KL, Clausen BH, Babcock AA, Gregersen R, Fenger C, Nielsen HH, Haugaard LS, Wirenfeldt M, Nielsen M, Dagnaes-Hansen F, Bluethmann H, Faergeman NJ, Meldgaard M, Deierborg T, Finsen B: Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J Neurosci. 2009, 29: 1319-1330. 10.1523/JNEUROSCI.5505-08.2009.View ArticlePubMed
- Clausen BH, Lambertsen KL, Babcock AA, Holm TH, Dagnaes-Hansen F, Finsen B: Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflammation. 2008, 5: 46-10.1186/1742-2094-5-46.PubMed CentralView ArticlePubMed
- Glezer I, Lapointe A, Rivest S: Innate immunity triggers oligodendrocyte progenitor reactivity and confines damages to brain injuries. FASEB J. 2006, 20: 750-752.PubMed
- Loane DJ, Byrnes KR: Role of microglia in neurotrauma. Neurotherapeutics. 2010, 7: 366-377. 10.1016/j.nurt.2010.07.002.PubMed CentralView ArticlePubMed
- Olah M, Amor S, Brouwer N, Vinet J, Eggen B, Biber K, Boddeke HW: Identification of a microglia phenotype supportive of remyelination. Glia. 2011, 60: 306-321.View ArticlePubMed
- Schonberg DL, Popovich PG, McTigue DM: Oligodendrocyte generation is differentially influenced by toll-like receptor (TLR) 2 and TLR4-mediated intraspinal macrophage activation. J Neuropathol Exp Neurol. 2007, 66: 1124-1135. 10.1097/nen.0b013e31815c2530.View ArticlePubMed
- Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG: Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci. 2009, 29: 13435-13444. 10.1523/JNEUROSCI.3257-09.2009.PubMed CentralView ArticlePubMed
- Kigerl KA, Lai W, Rivest S, Hart RP, Satoskar AR, Popovich PG: Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J Neurochem. 2007, 102: 37-50. 10.1111/j.1471-4159.2007.04524.x.View ArticlePubMed
- Bajetto A, Bonavia R, Barbero S, Florio T, Schettini G: Chemokines and their receptors in the central nervous system. Front Neuroendocrinol. 2001, 22: 147-184. 10.1006/frne.2001.0214.View ArticlePubMed
- Dziembowska M, Tham TN, Lau P, Vitry S, Lazarini F, Dubois-Dalcq M: A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors. Glia. 2005, 50: 258-269. 10.1002/glia.20170.View ArticlePubMed
- Li M, Chang CJ, Lathia JD, Wang L, Pacenta HL, Cotleur A, Ransohoff RM: Chemokine receptor CXCR4 signaling modulates the growth factor-induced cell cycle of self-renewing and multipotent neural progenitor cells. Glia. 2011, 59: 108-118. 10.1002/glia.21080.View ArticlePubMed
- Opatz J, Kury P, Schiwy N, Jarve A, Estrada V, Brazda N, Bosse F, Muller HW: SDF-1 stimulates neurite growth on inhibitory CNS myelin. Mol Cell Neurosci. 2009, 40: 293-300. 10.1016/j.mcn.2008.11.002.View ArticlePubMed
- Banisadr G, Frederick TJ, Freitag C, Ren D, Jung H, Miller SD, Miller RJ: The role of CXCR4 signaling in the migration of transplanted oligodendrocyte progenitors into the cerebral white matter. Neurobiol Dis. 2011, 44: 19-27.PubMed CentralPubMed
- Carbajal KS, Miranda JL, Tsukamoto MR, Lane TE: CXCR4 signaling regulates remyelination by endogenous oligodendrocyte progenitor cells in a viral model of demyelination. Glia. 2011, 59: 1813-1821. 10.1002/glia.21225.View ArticlePubMed
- Petty JM, Sueblinvong V, Lenox CC, Jones CC, Cosgrove GP, Cool CD, Rai PR, Brown KK, Weiss DJ, Poynter ME, Suratt BT: Pulmonary stromal-derived factor-1 expression and effect on neutrophil recruitment during acute lung injury. J Immunol. 2007, 178: 8148-8157.View ArticlePubMed
- Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA: A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med. 1996, 184: 1101-1109. 10.1084/jem.184.3.1101.View ArticlePubMed
- Hayashi H, Kume T: Forkhead transcription factors regulate expression of the chemokine receptor CXCR4 in endothelial cells and CXCL12-induced cell migration. Biochem Biophys Res Commun. 2008, 367: 584-589. 10.1016/j.bbrc.2007.12.183.PubMed CentralView ArticlePubMed
- Cruz-Orengo L, Chen YJ, Kim JH, Dorsey D, Song SK, Klein RS: CXCR7 antagonism prevents axonal injury during experimental autoimmune encephalomyelitis as revealed by in vivo axial diffusivity. J Neuroinflammation. 2011, 8: 170-10.1186/1742-2094-8-170.PubMed CentralView ArticlePubMed
- Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP: TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci. 2001, 4: 1116-1122. 10.1038/nn738.View ArticlePubMed
- Brambilla R, Ashbaugh JJ, Magliozzi R, Dellarole A, Karmally S, Szymkowski DE, Bethea JR: Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination. Brain. 2011, 134: 2736-2754. 10.1093/brain/awr199.PubMed CentralView ArticlePubMed
- Lambertsen KL, Clausen BH, Fenger C, Wulf H, Owens T, Dagnaes-Hansen F, Meldgaard M, Finsen B: Microglia and macrophages express tumor necrosis factor receptor p75 following middle cerebral artery occlusion in mice. Neuroscience. 2007, 144: 934-949. 10.1016/j.neuroscience.2006.10.046.View ArticlePubMed
- Wu J, Yoo S, Wilcock D, Lytle JM, Leung PY, Colton CA, Wrathall JR: Interaction of NG2(+) glial progenitors and microglia/macrophages from the injured spinal cord. Glia. 2010, 58: 410-422.PubMed CentralPubMed
- Foote AK, Blakemore WF: Inflammation stimulates remyelination in areas of chronic demyelination. Brain. 2005, 128: 528-539. 10.1093/brain/awh417.View ArticlePubMed
- Hvilsted Nielsen H, Toft-Hansen H, Lambertsen KL, Owens T, Finsen B: Stimulation of adult oligodendrogenesis by myelin-specific T cells. Am J Pathol. 2011, 179: 2028-2041. 10.1016/j.ajpath.2011.06.006.PubMed CentralView ArticlePubMed
- Kostianovsky AM, Maier LM, Anderson RC, Bruce JN, Anderson DE: Astrocytic regulation of human monocytic/microglial activation. J Immunol. 2008, 181: 5425-5432.View ArticlePubMed
- Ubogu EE, Cossoy MB, Ransohoff RM: The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol Sci. 2006, 27: 48-55. 10.1016/j.tips.2005.11.002.View ArticlePubMed
- Han Y, Wang J, He T, Ransohoff RM: TNF-alpha down-regulates CXCR4 expression in primary murine astrocytes. Brain Res. 2001, 888: 1-10. 10.1016/S0006-8993(00)02924-3.View ArticlePubMed
- Patel JR, McCandless EE, Dorsey D, Klein RS: CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proc Natl Acad Sci U S A. 2010, 107: 11062-11067. 10.1073/pnas.1006301107.PubMed CentralView ArticlePubMed
- Gottle P, Kremer D, Jander S, Odemis V, Engele J, Hartung HP, Kury P: Activation of CXCR7 receptor promotes oligodendroglial cell maturation. Ann Neurol. 2010, 68: 915-924. 10.1002/ana.22214.View ArticlePubMed
- Wang L, Wang Z, Yang B, Yang Q, Wang L, Sun Y: CXCR4 nuclear localization follows binding of its ligand SDF-1 and occurs in metastatic but not primary renal cell carcinoma. Oncol Rep. 2009, 22: 1333-1339.PubMed
- Farooque M, Isaksson J, Olsson Y: Improved recovery after spinal cord injury in neuronal nitric oxide synthase-deficient mice but not in TNF-alpha-deficient mice. J Neurotrauma. 2001, 18: 105-114. 10.1089/089771501750055811.View ArticlePubMed
- Patel JR, Williams JL, Muccigrosso MM, Liu L, Sun T, Rubin JB, Klein RS: Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS. Acta Neuropathol. 2012, 124: 847-860. 10.1007/s00401-012-1034-0.PubMed CentralView ArticlePubMed
- Kigerl KA, McGaughy VM, Popovich PG: Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury. J Comp Neurol. 2006, 494: 578-594. 10.1002/cne.20827.PubMed CentralView ArticlePubMed
- Sroga JM, Jones TB, Kigerl KA, McGaughy VM, Popovich PG: Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J Comp Neurol. 2003, 462: 223-240. 10.1002/cne.10736.View ArticlePubMed
- Trivedi A, Olivas AD, Noble-Haeusslein LJ: Inflammation and spinal cord injury: infiltrating leukocytes as determinants of injury and repair processes. Clin Neurosci Res. 2006, 6: 283-292. 10.1016/j.cnr.2006.09.007.PubMed CentralView ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.